[go: up one dir, main page]

IT1306165B1 - Impiego di inibitori della sostanza p per il trattamento degliadenocarcinomi. - Google Patents

Impiego di inibitori della sostanza p per il trattamento degliadenocarcinomi.

Info

Publication number
IT1306165B1
IT1306165B1 IT1999RM000426A ITRM990426A IT1306165B1 IT 1306165 B1 IT1306165 B1 IT 1306165B1 IT 1999RM000426 A IT1999RM000426 A IT 1999RM000426A IT RM990426 A ITRM990426 A IT RM990426A IT 1306165 B1 IT1306165 B1 IT 1306165B1
Authority
IT
Italy
Prior art keywords
denocarcinomas
inhibitors
substance
treatment
Prior art date
Application number
IT1999RM000426A
Other languages
English (en)
Inventor
Pierluigi Pompei
Maurizio Massi
Massimo Nabissi
Pier Luigi Sparapani
Original Assignee
Innova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innova Ltd filed Critical Innova Ltd
Priority to IT1999RM000426A priority Critical patent/IT1306165B1/it
Publication of ITRM990426A0 publication Critical patent/ITRM990426A0/it
Priority to CA002373960A priority patent/CA2373960A1/en
Priority to EP00953011A priority patent/EP1206259A2/en
Priority to US10/030,305 priority patent/US6576638B1/en
Priority to AU65616/00A priority patent/AU6561600A/en
Priority to JP2001507420A priority patent/JP2003503429A/ja
Priority to PCT/EP2000/006309 priority patent/WO2001001922A2/en
Publication of ITRM990426A1 publication Critical patent/ITRM990426A1/it
Application granted granted Critical
Publication of IT1306165B1 publication Critical patent/IT1306165B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT1999RM000426A 1999-07-05 1999-07-05 Impiego di inibitori della sostanza p per il trattamento degliadenocarcinomi. IT1306165B1 (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT1999RM000426A IT1306165B1 (it) 1999-07-05 1999-07-05 Impiego di inibitori della sostanza p per il trattamento degliadenocarcinomi.
CA002373960A CA2373960A1 (en) 1999-07-05 2000-07-05 Use of substance p antagonists for the treatment of adenocarcinoma
EP00953011A EP1206259A2 (en) 1999-07-05 2000-07-05 Use of substance p antagonists for the treatment of adenocarcinoma
US10/030,305 US6576638B1 (en) 1999-07-05 2000-07-05 Use of substance P antagonists in the treatment of the adenocarcinomas
AU65616/00A AU6561600A (en) 1999-07-05 2000-07-05 Use of substance p antagonists in the treatment of the adenocarcinomas
JP2001507420A JP2003503429A (ja) 1999-07-05 2000-07-05 腺ガンの治療におけるサブスタンスｐ拮抗薬の使用方法
PCT/EP2000/006309 WO2001001922A2 (en) 1999-07-05 2000-07-05 Use of substance p antagonists for the treatment of adenocarcinoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999RM000426A IT1306165B1 (it) 1999-07-05 1999-07-05 Impiego di inibitori della sostanza p per il trattamento degliadenocarcinomi.

Publications (3)

Publication Number Publication Date
ITRM990426A0 ITRM990426A0 (it) 1999-07-05
ITRM990426A1 ITRM990426A1 (it) 2001-01-05
IT1306165B1 true IT1306165B1 (it) 2001-05-30

Family

ID=11406865

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999RM000426A IT1306165B1 (it) 1999-07-05 1999-07-05 Impiego di inibitori della sostanza p per il trattamento degliadenocarcinomi.

Country Status (7)

Country Link
US (1) US6576638B1 (it)
EP (1) EP1206259A2 (it)
JP (1) JP2003503429A (it)
AU (1) AU6561600A (it)
CA (1) CA2373960A1 (it)
IT (1) IT1306165B1 (it)
WO (1) WO2001001922A2 (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002259147A1 (en) * 2001-05-08 2002-11-18 Schering Corporation Use of neurokinin receptor antagonists to treat androgen-dependent diseases
WO2004087165A1 (ja) * 2003-03-28 2004-10-14 Sankyo Company Limited 前立腺肥大症治療薬
ES2246687B2 (es) * 2004-02-11 2006-11-16 Miguel Muñoz Saez Utilizacion de antagonistas no peptidicos de receptores nk1 para la produccion de apoptosis en celulas tumorales.
EP1809104A4 (en) * 2004-09-23 2009-04-29 Alexander Michalow METHODS FOR REGULATING NEUROTRANSMITTER SYSTEMS BY INDUCING COUNTER-ADAPTATIONS
US20080045610A1 (en) * 2004-09-23 2008-02-21 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
KR20090035279A (ko) * 2007-10-05 2009-04-09 경희대학교 산학협력단 위장관 손상 예방 및 치료용 조성물
ES2433840T3 (es) 2008-04-09 2013-12-12 Universidad De Barcelona Anticuerpos para el tratamiento del cáncer
ES2376564B1 (es) 2010-08-12 2013-01-24 Manuel Vicente Salinas Martín Utilización de anticuerpos contra los receptores nk1, nk2 y/o nk3, para producir apoptosis en las células tumorales y modificar el estroma, la inmunidad y la vascularización intra y peritumorales, como tratamiento del cáncer.
CN102188424B (zh) * 2011-03-23 2013-03-27 浙江理工大学 Sr140333的抗血癌作用
EP2837381A4 (en) 2011-12-13 2015-12-09 Servicio Andaluz De Salud USE OF MEDICAMENTS FOR THE TREATMENT OF CANCER THAT CHANGE THE PERITUMORAL ENVIRONMENT
ES2493693B1 (es) 2013-02-11 2015-07-07 Servicio Andaluz De Salud Método para predecir o pronosticar la respuesta de un sujeto humano que padece un cáncer al tratamiento con un antagonista del receptor NK1
ES2541870B1 (es) 2013-12-27 2016-05-12 Servicio Andaluz De Salud Uso de antagonistas no peptídicos de NK1 en una determinada dosis para el tratamiento del cáncer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004494A1 (en) * 1992-08-13 1994-03-03 Warner-Lambert Company Tachykinin antagonists
EP0659409A3 (en) 1993-11-23 1995-08-09 Pfizer Substance P antagonists for the inhibition of angiogenesis.
CA2189501A1 (en) 1995-11-06 1997-05-07 Harry R. Howard Nk-1 receptor antagonists for the treatment of cancer
EP0835662B1 (en) 1996-10-08 2001-11-14 National Institute of Immunology A drug for the treatment of cancer

Also Published As

Publication number Publication date
AU6561600A (en) 2001-01-22
WO2001001922A3 (en) 2001-05-10
WO2001001922A2 (en) 2001-01-11
CA2373960A1 (en) 2001-01-11
EP1206259A2 (en) 2002-05-22
JP2003503429A (ja) 2003-01-28
US6576638B1 (en) 2003-06-10
ITRM990426A0 (it) 1999-07-05
ITRM990426A1 (it) 2001-01-05

Similar Documents

Publication Publication Date Title
NO20021329D0 (no) Kinaseinhibitorer som terapeutiske midler
FI20000863A0 (fi) Uusi hoitomenetelmä
AR028253A1 (es) Inhibidores de la glucogeno fosforilasa
PT1181017E (pt) Inibidores de metaloproteases
EE200200145A (et) Retigabiini kasutamine neuropaatilise valu raviks
DE60020259D1 (de) C-aryl-glucosid-sglt2-inhibitoren
ITMI991608A0 (it) Sonda elettrochirurgica per il trattamento di tumori mediante radiofre quenza
PT1194404E (pt) Inibidores de aspartil-protease
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
PT1206436E (pt) Retinoides para o tratamento de enfisema
IT1306165B1 (it) Impiego di inibitori della sostanza p per il trattamento degliadenocarcinomi.
ITNA20000036A0 (it) Nuovi approcci terapeutici per il trattamento della forfora.
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
NO20024777D0 (no) Kinolinyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
IT1303677B1 (it) Dispositivo per il trattamento termico di pezzi.
NO20013596L (no) Slambehandling
ITGE20020050A0 (it) Procedimento per il trattamento di filati mediante agugliatura.
IT250667Y1 (it) Dispositivo per la lavorazione di cerchioni
DK1224181T3 (da) Substituerede pyrroler som antiproliferative midler til behandling af cancer
IT1306822B1 (it) Calzoncino per il trattamento topico della cellulite.
IT1316554B1 (it) Dispositivo per il trattamento di rifiuti umidi.
ITMI20000147A0 (it) Procedimeto per il trattamento di fanghi
ITMI20021205A0 (it) Uso di proteine per il trattamento della leishmaniosi
IT1311582B1 (it) Ortesi ortopedica per il trattamento di epicondiliti.
ITMI991329A0 (it) Procedimento per la preparazione di tetrafluoroalogenobenzeni